Fronza Filippo, Groff Nelli, Martinelli Angela, Passerini Beatrice Zita, Rensi Nicolò, Cortelletti Irene, Vivori Nicolò, Adami Valentina, Helander Anna, Bridi Simone, Pancher Michael, Greco Valentina, Garritano Sonia Iolanda, Piffer Elena, Stefani Lara, De Sanctis Veronica, Bertorelli Roberto, Pancheri Serena, Collini Lucia, Dassi Erik, Quattrone Alessandro, Capobianchi Maria Rosaria, Icardi Giancarlo, Poli Guido, Caciagli Patrizio, Ferro Antonio, Pizzato Massimo
Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.
Azienda Provinciale per i Servizi Sanitari, 38123 Trento, Italy.
Viruses. 2022 Feb 2;14(2):313. doi: 10.3390/v14020313.
Efficient, wide-scale testing for SARS-CoV-2 is crucial for monitoring the incidence of the infection in the community. The gold standard for COVID-19 diagnosis is the molecular analysis of epithelial secretions from the upper respiratory system captured by nasopharyngeal (NP) or oropharyngeal swabs. Given the ease of collection, saliva has been proposed as a possible substitute to support testing at the population level. Here, we used a novel saliva collection device designed to favour the safe and correct acquisition of the sample, as well as the processivity of the downstream molecular analysis. We tested 1003 nasopharyngeal swabs and paired saliva samples self-collected by individuals recruited at a public drive-through testing facility. An overall moderate concordance (68%) between the two tests was found, with evidence that neither system can diagnose the infection in 100% of the cases. While the two methods performed equally well in symptomatic individuals, their discordance was mainly restricted to samples from convalescent subjects. The saliva test was at least as effective as NP swabs in asymptomatic individuals recruited for contact tracing. Our study describes a testing strategy of self-collected saliva samples, which is reliable for wide-scale COVID-19 screening in the community and is particularly effective for contact tracing.
对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进行高效、大规模检测对于监测社区感染发病率至关重要。2019冠状病毒病(COVID-19)诊断的金标准是对通过鼻咽拭子或口咽拭子采集的上呼吸道上皮分泌物进行分子分析。鉴于采集方便,唾液已被提议作为一种可能的替代样本,以支持人群层面的检测。在此,我们使用了一种新型唾液采集装置,该装置旨在便于安全、正确地采集样本,以及便于下游分子分析的流程化操作。我们对在一个公共免下车检测设施招募的个体自行采集的1003份鼻咽拭子和配对唾液样本进行了检测。发现两种检测之间总体一致性中等(68%),有证据表明两个系统都不能在100%的病例中诊断出感染。虽然两种方法在有症状个体中表现同样良好,但它们的不一致主要局限于康复期受试者的样本。在为接触者追踪而招募的无症状个体中,唾液检测至少与鼻咽拭子检测一样有效。我们的研究描述了一种自行采集唾液样本的检测策略,该策略对于社区中大规模的COVID-19筛查是可靠的,并且对于接触者追踪特别有效。